How the rare disease community has developed fertile ground ...

Amanda Barrell explores how a perfect storm of changing economics, advances in technology, and the increasing volume of the patient voice is stoking change in the rare disease space.

BioNTech, InstaDeep plan joint lab for AI research

BioNTech may be deeply ensconced in the latter stages of its bid to bring a COVID-19 vaccine to market, but it’s still pushing forward on other fronts, including a partnership with InstaDee

BMS joins forces with insitro to develop neurodegenerative t...

insitro has landed another big biopharma partnership, signing a five-year collaboration with Bristol Myers Sqibb to develop therapies for amyotrophic lateral sclerosis (ALS) and frontotempo

BERG taps supercomputer to speed AI discovery of COVID-19 dr...

US artificial intelligence company BERG has agreed a deal to access a federal supercomputer to help it hunt down drugs to treat coronavirus.

AI drug discovery firm Exscientia gets $60M cash injection

UK artificial intelligence specialist Exscientia has topped up its coffers with a $60 million Series C funding round that will be used to advance projects into clinical trials.

Home PCs recruited to hunt down COVID-19 therapies